Welcome to our dedicated page for Macy's SEC filings (Ticker: M), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Macy’s, Inc. filings document the public-company disclosures of a retail operator with the Macy’s, Bloomingdale’s and Bluemercury nameplates. Recent Form 8-K reports cover operating results, financial condition, cash flows, non-GAAP measures such as adjusted EBITDA and adjusted earnings, and updates to financial disclosure metrics tied to the company’s go-forward business and comparable-sales reporting.
The company’s proxy and other current reports also describe shareholder meeting matters, board composition, director elections, executive compensation, compensatory arrangements and governance changes. These filings frame Macy’s capital-market reporting around retail performance, disclosure controls, governance structure and shareholder voting processes.
Macy's, Inc. (M) filed a Form 144 notifying a proposed sale of 200,000 shares of Common Stock through Charles Schwab & Co. with an aggregate market value of $3,448,000.00 and approximately 271,539,526 shares outstanding. The securities listed were acquired via restricted stock and performance restricted stock vesting on dates from 07/09/2021 through 03/23/2023 as compensation from Macy's, Inc. The filing shows no reported sales in the past three months and includes the seller's representation that they know of no undisclosed material adverse information.
Macy’s, Inc. filed a current report describing the release of its financial results for the 13- and 26-week periods ended August 2, 2025. On September 3, 2025, the company issued a press release covering its financial condition, results of operations and cash flows for those periods.
The release, incorporated by reference as Exhibit 99.1, presents results under GAAP and also includes non-GAAP metrics such as comparable sales on an owned-plus-licensed-plus-marketplace basis, EBITDA, adjusted EBITDA, core adjusted EBITDA, adjusted net income and adjusted diluted earnings per share, with reconciliation tables to the nearest GAAP measures.
Schedule 13G filed for MACYS INC (CUSIP 55616P104). FMR LLC reports beneficial ownership of 14,026,410.51 shares, representing 5.2% of Macy's common stock as of the event date 06/30/2025. Abigail P. Johnson is also reported with sole dispositive power over the same 14,026,410.51 shares. The filing is signed on 08/05/2025.
Addresses and roles: Issuer principal executive office is listed at 151 West 34th Street, New York, NY 10001. FMR LLC principal business office is 245 Summer Street, Boston, MA 02210. The statement affirms the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
Other disclosures:
- No shared voting or dispositive power is reported.
- One or more other persons may have rights to dividends or proceeds but no other person's interest exceeds 5%.
Macy's EVP, COO & CFO Thomas Edwards Jr. received two significant grants of Restricted Stock Units (RSUs) on June 23, 2025:
- 103,383 RSUs with a split vesting schedule: 50% vesting on both second and third anniversaries of grant date
- 145,676 RSUs with quarterly vesting: 25% vesting annually over four years
The total grant of 249,059 RSUs represents an equivalent number of Macy's common stock shares. Each RSU was granted at $0 exercise price, indicating these are time-based equity compensation awards rather than performance-based options. This substantial equity grant suggests a long-term retention strategy for the senior executive, with vesting schedules extending up to four years to encourage continued service.